1. Clinical development of hepatitis C virus host-targeting agents. Issue 10070 (18th February 2017) Authors: Zeisel, Mirjam B; Baumert, Thomas F Journal: Lancet Issue: Volume 389:Issue 10070(2017) Page Start: 674 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Combined small molecule and loss-of-function screen uncovers estrogen receptor alpha and CAD as host factors for HDV infection and antiviral targets. Issue 1 (4th March 2019) Authors: Verrier, Eloi R; Weiss, Amélie; Bach, Charlotte; Heydmann, Laura; Turon-Lagot, Vincent; Kopp, Arnaud; El Saghire, Houssein; Crouchet, Emilie; Pessaux, Patrick; Garcia, Thomas; Pale, Patrick; Zeisel, Mirjam B; Sureau, Camille; Schuster, Catherine; Brino, Laurent; Baumert, Thomas F Journal: Gut Issue: Volume 69:Issue 1(2020) Page Start: 158 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Functional microRNA screen uncovers O-linked N-acetylglucosamine transferase as a host factor modulating hepatitis C virus morphogenesis and infectivity. Issue 2 (10th May 2019) Authors: Herzog, Katharina; Bandiera, Simonetta; Pernot, Sophie; Fauvelle, Catherine; Jühling, Frank; Weiss, Amélie; Bull, Anne; Durand, Sarah C; Chane-Woon-Ming, Béatrice; Pfeffer, Sébastien; Mercey, Marion; Lerat, Hervé; Meunier, Jean-Christophe; Raffelsberger, Wolfgang; Brino, Laurent; Baumert, Thomas ... Journal: Gut Issue: Volume 69:Issue 2(2020) Page Start: 380 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. HCV entry and neutralizing antibodies: lessons from viral variants. (June 2009) Authors: Zeisel, Mirjam B; Baumert, Thomas F Journal: Future microbiology Issue: Volume 4:Number 5(2009) Page Start: 511 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Humanisation of a claudin-1-specific monoclonal antibody for clinical prevention and cure of HCV infection without escape. Issue 4 (30th March 2017) Authors: Colpitts, Che C; Tawar, Rajiv G; Mailly, Laurent; Thumann, Christine; Heydmann, Laura; Durand, Sarah C; Xiao, Fei; Robinet, Eric; Pessaux, Patrick; Zeisel, Mirjam B; Baumert, Thomas F Journal: Gut Issue: Volume 67:Issue 4(2018) Page Start: 736 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. MiR-135a-5p-mediated downregulation of protein tyrosine phosphatase receptor delta is a candidate driver of HCV-associated hepatocarcinogenesis. Issue 5 (3rd February 2017) Authors: Van Renne, Nicolaas; Roca Suarez, Armando Andres; Duong, Francois H T; Gondeau, Claire; Calabrese, Diego; Fontaine, Nelly; Ababsa, Amina; Bandiera, Simonetta; Croonenborghs, Tom; Pochet, Nathalie; De Blasi, Vito; Pessaux, Patrick; Piardi, Tullio; Sommacale, Daniele; Ono, Atsushi; Chayama, Kazuaki... Journal: Gut Issue: Volume 67:Issue 5(2018) Page Start: 953 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C. Issue 3 (21st May 2014) Authors: Xiao, Fei; Fofana, Isabel; Thumann, Christine; Mailly, Laurent; Alles, Roxane; Robinet, Eric; Meyer, Nicolas; Schaeffer, Mickaël; Habersetzer, François; Doffoël, Michel; Leyssen, Pieter; Neyts, Johan; Zeisel, Mirjam B; Baumert, Thomas F Journal: Gut Issue: Volume 64:Issue 3(2015) Page Start: 483 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Synthetic anti-lipopolysaccharide peptides and hepatitis C virus infection. (November 2013) Authors: Habersetzer, François; Leboeuf, Céline; Doffoël, Michel; Zeisel, Mirjam B; Baumert, Thomas F Journal: Expert opinion on investigational drugs Issue: Volume 22:Number 7(2013:Jul.) Page Start: 853 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma. Issue 1 (26th March 2020) Authors: Jühling, Frank; Hamdane, Nourdine; Crouchet, Emilie; Li, Shen; El Saghire, Houssein; Mukherji, Atish; Fujiwara, Naoto; Oudot, Marine A; Thumann, Christine; Saviano, Antonio; Roca Suarez, Armando Andres; Goto, Kaku; Masia, Ricard; Sojoodi, Mozhdeh; Arora, Gunisha; Aikata, Hiroshi; Ono, Atsushi; Ta... Journal: Gut Issue: Volume 70:Issue 1(2021) Page Start: 157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma. Issue 1 (26th March 2020) Authors: Jühling, Frank; Hamdane, Nourdine; Crouchet, Emilie; Li, Shen; El Saghire, Houssein; Mukherji, Atish; Fujiwara, Naoto; Oudot, Marine A; Thumann, Christine; Saviano, Antonio; Roca Suarez, Armando Andres; Goto, Kaku; Masia, Ricard; Sojoodi, Mozhdeh; Arora, Gunisha; Aikata, Hiroshi; Ono, Atsushi; Ta... Journal: Gut Issue: Volume 70:Issue 1(2021) Page Start: 157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗